[1] 成长鑫,王波,张艳,等.CMR在高血压心脏病中的应用进展[J].磁共振像,2024,15(2):208-212.
[2] Tadic M, Cuspidi C, Plein S, et al.Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus[J]. Heart Fail Rev, 2021, 26(6): 1383-1390.
[3] Nguyen J, Weber J, Hsu B,et al.Comparing left atrial indices by CMR in association with left ventricular diastolic dysfunction and adverse clinical outcomes[J/OL]. Sci Rep, 2021, 11(1): 21331.
[4] Ismail TF, Frey S, Kaufmann BA,et al.Hypertensive heart disease-the imaging perspective[J]. J Clin Med, 2023, 12(9): 3122.
[5] 赵猛,李志强,曹强,等.心脏MRI延迟强化联合T1 Mapping技术在高血压性心脏病心肌纤维化评价中的应用价值[J].医学影像学杂志,2022,32(11):1897-1901.
[6] 张恒,郭应坤.高血压性心脏病的心脏磁共振评估研究进展[J].放射学实践,2022,37(9):1177-1181.
[7] Zhou W, Brown JM, Bajaj NS, et al.Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure[J]. Eur Heart J, 2020, 41(25): 2366-2375.
[8] 向晓睿,赵世华.高血压性心脏病磁共振成像现状与进展[J].中国循环杂志,2022,37(10):1069-1072.
[9] Niu J, Zeng M, Wang Y, et al.Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain[J/OL]. BMC Cardiovasc Disord, 2020, 20(1): 292
[10] 夏睿,陶黎,廖继春,等.高血压性心脏病患者左室心肌纤维化与左房功能参数相关性的初步研究[J].磁共振成像,2022,13(12):20-25. |
